News DexCare raises $75m for digital patient booking system DexCare has topped up its finances with a $75 million third round that will be used to fund the continued roll-out of its patient appointment booking platform.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.